Crossref

1. Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effect

- Xue Li

- Hongyuan Zheng

- Chao Ma

- Yanhui Ji

- Xuan Wang

- Danyang Sun

- Zhaowei Meng

- Wei Zheng

2. Radioactive Iodine in Differentiated Carcinoma of Thyroid: An Overview

- Namit Kant Singh

- Balaji Ramamourthy

- Neemu Hage

- Sushmitha Nagaraju

- Krishna Medha Kappagantu

3. Recombinant Human Thyrotropin Plus Radioactive Iodine Among Patients With Thyroid Cancer

- Hui Tan

- Yushen Gu

- Yan Xiu

- Xingmin Han

- Qiang Wen

- Zhongwei Lv

- Wei Fan

- Sijin Li

- Jian Tan

- Feng Wang

- Wei Fu

- Yifan Zhang

- Jun Xin

- Wei Ouyang

- Xuemei Wang

- Bin Liu

- Yue Chen

- Xuegong Liu

- Yi Mo

- Quanyong Luo

- Jing Wang

- Meng Li

- Yan Di

- Tao Xu

- Hongcheng Shi

4. Real-world Data on Intermediate-risk Differentiated Thyroid Cancer Biochemical Response to 3700 or 5550 MBq of [131I]Sodium Iodide

- Daniel M. Machado

- Daniel A. Bulzico

- Lidia F. Fontes

- Rossana C. R. de Mello

- Simone Basso Locatelli

- Priscilla B. Pujatti